Bate Kenneth
CIK 0001210238
Director
Filings
17
Latest Jan 23, 2026
Issuers covered
4
Showing
17 of 17
Page 1
Track record
43 of 43 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 43 | 60% | -1.3% | +1.3% | +17.7% | -21.3% |
| 90 days | 43 | 21% | -6.2% | -9.2% | +19.3% | -39.2% |
| 180 days | 43 | 40% | -5.9% | -9.0% | +17.0% | -30.1% |
| 365 days | 26 | 0% | -30.1% | -28.7% | -26.7% | -36.9% |
Issuers
Companies where Bate Kenneth has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals, Inc. | 8 | Nov 7, 2025 |
| ATXS | Astria Therapeutics, Inc. | 6 | Jan 23, 2026 |
| AVEO | Aveo Pharmaceuticals, Inc. | 2 | Jan 19, 2023 |
| EPZM | Epizyme, Inc. | 1 | May 19, 2022 |
All filings
17 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|